Skip to main content
NHP logo

NHP · National Healthcare Properties, Inc.

Track NHP — free
$15.16 -0.04 (-0.23%)
Ex-dividend: $0.075 · Oct 9, 2026 Return incl. dividend (before tax) +0.26%
Market Cap
$1.11B
Shares
72.90M
Volume · Oct 9 31.63K Avg daily vol (3M) 621.32K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$15.19 Open$15.32 Day$15.15–15.53 Available close range$12.00–17.08 Avg vol 30d654K Short int3.9M · 5.3% float · 10.3d Short vol50% Last earningsNov 5, 2026 DataApr 2026–Oct 2026 Filing10-Q · Aug 6

The closing range uses available history since Apr 22, 2026; less than a full year is stored.

Up next

Next earnings release
Nov 4, 2026 Announced · in 4 wks
Next earnings call
Nov 5, 2026 Scheduled · in 4 wks
filed Aug 6, 2026
call held Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
0.5%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
5.3%
Latest settlement · 10.3 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Limited Sentiment Neutral Fundamentals Fair Quant / Vol Low
Market backdrop VIX 15.4 · calm Equity put/call 0.62
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −6%
below
RSI (14) 32
neutral
MACD trend Negative
52-week position 63%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
2 of 94 funds reported for Sep 30 · net +149 sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.31% of float · ▲ +9.6% MoM · 10.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
94 holders — near 5-yr high, broad support
Squeeze score 78
high risk · 0–100
Fundamentals
Fair
Revenue growth −3%
Y/Y
Gross margin 36%
contracting
EPS growth +65%
Y/Y
Free cash flow $-9.8M
Buyback $50.0M
authorized
Quant / Vol
risk profile
Low
Volatility 34%
annualized · 1-yr
Max drawdown −11%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 5, 2026
SHOP Same Store Cash NOI growth · full year 2026 Non-GAAP Initiated 15% – 18%
OMF Same Store Cash NOI growth · full year 2026 Non-GAAP Initiated 2.5% – 3.5%
Acquisitions · full year 2026 Initiated $375M – $425M
Dispositions · full year 2026 Initiated $570M
General and administrative expense, including equity-based compe · full year 2026 Initiated $27M – $28M
Equity-based compensation · full year 2026 Initiated $6M – $7M
Same Store Recurring Capital Expenditures · full year 2026 Initiated $22M – $25M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−6% Bearish
RSI (14)
32 Neutral
MACD trend
Negative Bearish
52-week position
63% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
2 of 94 funds reported for Sep 30 · net +149 sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.31% of float · ▲ +9.6% MoM · 10.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
94 holders — near 5-yr high, broad support
Price context
position in its available closing range
Range low $12 Now $15 · 63% Range high $17
vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Average monthly revenue per occupied room $6,391 Three months ended June 30, 2026 filing —
Average occupancy 84.1% Three months ended June 30, 2026 filing —
NAREIT FFO attributable to common stockholders non-GAAP $11.95M Three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net loss attributable to common stockholders -$8.14M
+$16.4M Depreciation and amortization related to real estate assets
+$3.78M Impairment charges
+$0K Loss (gain) on sale of real estate investments
-$89K Depreciation on real estate assets related to non-controlling interests
= NAREIT FFO attributable to common stockholders $11.95M
NOI non-GAAP $31.15M Three months ended June 30, 2025 filing —
Normalized NFFO attributable to common stockholders non-GAAP $10.87M Three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP NAREIT FFO attributable to common stockholders $11.95M
+$130K Acquisition and transaction related
-$1.24M Derivatives mark-to-market and terminations
+$7K Casualty-related charges, net
+$0K Gain on extinguishment of debt
-$7K Normalizing items related to non-controlling interests
+$21K Other normalizing items
= Normalized NFFO attributable to common stockholders $10.87M
Occupancy at June 30 93.1% the three months ended June 30, 2026 filing —
Total communities 39 the three months ended June 30, 2026 filing —
OMF Same Store Cash NOI growth non-GAAP -0.4% Q2 2026 —
OMF Same Store ending occupancy non-GAAP 94.3% Q2 2026 —
SHOP Same Store average occupancy non-GAAP 84.1% Q2 2026 —
SHOP Same Store Cash NOI growth non-GAAP 20.1% Q2 2026 —
SHOP Same Store Cash NOI Margin non-GAAP 22.4% Q2 2026 —
SHOP Same Store RevPOR non-GAAP 5.9% Q2 2026 —
Total Facility non-GAAP $1.2B As of August 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NHP
National Healthcare Properties, Inc.
this stock
$1.11B — -3.3% — 5.3%
WELL
Welltower Inc.
$157.45B +20.2% +35.6% 111.0 2.5%
VTR
Ventas, Inc.
$41.94B +5.7% +18.5% 151.4 3.9%
OHI
Omega Healthcare Investors Inc
$13.37B -0.5% +13.2% 15.7 4.8%
DOC
Healthpeak Properties, Inc.
$12.77B +15.2% +4.5% 52.9 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
96
% held
73.7%
Reported
2 of 94
Top holder
PRINCIPAL FINANCIAL GROUP…
Held Float
View
Held by Funds
Fund positions
109
View
Short & Settlement
Short Interest Rising
Shares short
3.9M
Days to cover
10.3d
Change
+339.4K sh
View
Short Volume
Short vol %
50%
As of
Oct 8, 2026
Short Total
View
Fails to Deliver
FTD shares
87.7K
Value
$1.4M
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
43.1%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$342.3M
Net income (FY)
$-88.1M
EPS diluted
$-2.51
View
Buybacks
Authorized
$50.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 29, 2026
This year
20
View
Exempt Offerings
Offering
$15.0M
Filed
Aug 24, 2021
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 5, 2026
Last webcast
Aug 6, 2026
View
Investor Relations
Latest news
National Healthcare Properties An…
Published
Oct 6, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
NHP -5.8% -5.3% — -5.3% —
SPY +1.3% +2.1% +9.0% +1.5% +13.5%
vs SPY -7.1% -7.4% — -6.8% —

Capital returns

Latest dividend
$0.075 / share · ex Oct 9, 2026
Paid (TTM)
$0.15 / share · 2 payouts
Dividend yield (TTM, derived)
— · history filling in
Buyback program · as of May 2, 2025
Authorized
$50.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1561032 CUSIP 42226B501 13F (30d) 5 filings 5 filers Visit website Investor relations